A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

Some drugmakers' submission of multiple "use codes" to expand patent claims appears to be delaying the arrival of lower-cost ...

How drugmakers have relied on "use codes" to vastly expand the nature of their patent claims, keeping prices higher.

DEHP, a cancer-causing chemical, is widely present in IV devices used to treat cancer. California is poised to take action, ...

In the months after the retraction, Chris Ferguson, a psychologist at Stetson University and an editor at a different ...

The process for translating clinical trial results into action for young women in Africa has been left to our imaginations, ...

The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients ...

Democrats are pursuing new attack lines ahead of an election that many see as a referendum on reproductive rights.

A U.S. government agency has threatened Johnson & Johnson with sanctions if the company proceeds with plans to alter payment ...

GOP vice presidential-hopeful JD Vance made some confusing comments over the weekend about deregulating health insurance.

Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only ...